The Stockholm stock market experienced volatility over the past two days, with the OMXS30 index closing down 0.3% on March 19. Saab saw a notable decline, falling nearly 8% on March 19 due to a sell recommendation, and a total drop of 5.3% after a negative report from Dagens Industri regarding Norion and Balder. In contrast, Dignitana surged approximately 70% following a bid announcement, while Sedana Medical plummeted nearly 50% due to disappointing study results. The overall market sentiment was mixed, with Nibe rising to the top of the large-cap index, while the broader index, OMXSPI, remained marginally up.
Stockholmsbörsen sjönk under dagen – OMXS30 ned 0,3% https://t.co/9rP9DR4hmc
↘ OMXS30 -0,3% | Blandat avslut efter volatil handelsdag i Stockholm • DI:s granskning sänkte Norion och Balder • Saab föll 5,3 procent efter säljrek https://t.co/FjigyGDAll
Svängig börsdag slutade i sidled – OMXSPI marginellt upp • Saab rasade efter säljstämpel – Selinbolag föll efter Di:s Noriongranskning. https://t.co/G217Z2UY2I